Nuvectis Pharma, Inc. (NVCT) Stock Price & Growth Analysis

Quote Panel

Updated January 13, 2025

1W -8.35 % 1M 17.25 % 3M -11.47 % 1Y -22.84 %

Key Metrics

Market Cap
110.32M
Shares Outstanding
19.32M
Share in Float
8.28M
Dividende
0

Earning Date
04 Mar 2025
Price Target
5.71
Average Volume
184108
Beta
0.404

Range
4.44-12.1
Industry
Biotechnology
Website
https://www.nuvectis.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

Nanx

P/S Ratio

9.11x

P/B Ratio

0.0

Debt/Equity

472.4%

Net Margin

$-1.2

EPS

How NVCT compares to sector?

P/E Ratio

Fundamentals

Relative Strength

NVCT

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$23M

NaN%

2025-Revenue

$0.95

-294%

2025-EPS

$12M

365%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q4.22

N/A

-0.48
vs -0.48

Q1.23

N/A

-0.27
vs -0.32

Q2.23

N/A

-0.38
vs -0.28

Q3.23

N/A

-0.37
vs -0.42

Q4.23

N/A

-0.41
vs -0.48

Q1.24

N/A

-0.25
vs -0.27

Q2.24

N/A

-0.26
vs -0.38

Q3.24

N/A

-0.24
vs -0.37

Q4.24

N/A

-0.25
vs -0.41

Q1.25

N/A

-0.21
vs -0.25

Sales Growth

YoY

Current

Estimates

Q2.22

NA vs NA

Q3.22

NA vs NA

Q4.22

+3625%

149K vs 4K

Q1.23

4.1M vs NA

Q2.23

NA vs NA

Q3.23

NA vs NA

Q4.23

-2852%

-4101000.00 vs 149K

Q1.24

-100%

NA vs 4.1M

Q2.24

NA vs NA

Q3.24

NA vs NA

Return on Equity

QoQ

Q4.22

-46%

-0.46
vs -0.29

Q1.23

-33%

-0.33
vs -0.46

Q2.23

-28%

-0.28
vs -0.33

Q3.23

-35%

-0.35
vs -0.28

Q4.23

-54%

-0.54
vs -0.35

Q1.24

-30%

-0.30
vs -0.54

Q2.24

-35%

-0.35
vs -0.30

Q3.24

-38%

-0.38
vs -0.35

Institutionnal Ownership

QoQ

Q4.22

11
vs 11

Q1.23

13
vs 11

18%

Q2.23

37
vs 13

185%

Q3.23

33
vs 37

-11%

Q4.23

36
vs 33

Q1.24

40
vs 36

11%

Q2.24

39
vs 40

-2%

Q3.24

31
vs 39

-21%

Earnings Growth

YoY

Current

Estimates

Q4.22

N/A

-0.48
vs -0.48

Q1.23

N/A

-0.27
vs -0.32

Q2.23

N/A

-0.38
vs -0.28

Q3.23

N/A

-0.37
vs -0.42

Q4.23

N/A

-0.41
vs -0.48

Q1.24

N/A

-0.25
vs -0.27

Q2.24

N/A

-0.26
vs -0.38

Q3.24

N/A

-0.24
vs -0.37

Q4.24

N/A

-0.25
vs -0.41

Q1.25

N/A

-0.21
vs -0.25

Sales Growth

YoY

Current

Estimates

Q2.22

NA vs NA

Q3.22

NA vs NA

Q4.22

+3625%

149K vs 4K

Q1.23

4.1M vs NA

Q2.23

NA vs NA

Q3.23

NA vs NA

Q4.23

-2852%

-4101000.00 vs 149K

Q1.24

-100%

NA vs 4.1M

Q2.24

NA vs NA

Q3.24

NA vs NA

Return on Equity

QoQ

Q4.22

-46%

-0.46
vs -0.29

Q1.23

-33%

-0.33
vs -0.46

Q2.23

-28%

-0.28
vs -0.33

Q3.23

-35%

-0.35
vs -0.28

Q4.23

-54%

-0.54
vs -0.35

Q1.24

-30%

-0.30
vs -0.54

Q2.24

-35%

-0.35
vs -0.30

Q3.24

-38%

-0.38
vs -0.35

Institutionnal Ownership

QoQ

Q4.22

11
vs 11

Q1.23

13
vs 11

18%

Q2.23

37
vs 13

185%

Q3.23

33
vs 37

-11%

Q4.23

36
vs 33

Q1.24

40
vs 36

11%

Q2.24

39
vs 40

-2%

Q3.24

31
vs 39

-21%

Company Description

N/A

Nanx

9.11x

0.0

472.4%

$-1.2

$23M

$0.95

$12M

Earnings Growth

Latest News

New Feature Coming Soon, Stay Tuned!

Earnings Growth

N/A

Nanx

9.11x

0.0

472.4%

$-1.2